Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrik Finne

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Calcified Tissue International|October 20, 2021
Clinical Prediction of High-Turnover Bone Disease After Kidney TransplantationSatu M Keronen, Leena A L Martola, Patrik Finne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinomaTiina-Liisa Erkinheimo, Heini Lassus, Patrik Finne, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 8, 2025
Effectiveness of COVID-19 vaccination among dialysis and kidney transplant patients compared with matched controls-a nationwide cohort studyHanna Helanne, Elisa Kortela, Jaakko Helve, et al.
European Urology|June 21, 2002
Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examinationPatrik Finne, Anssi Auvinen, Jussi Aro, et al.
International Journal of Cancer|August 10, 2004
Test sensitivity of prostate-specific antigen in the Finnish randomised prostate cancer screening trialAnssi Auvinen, Liisa Määttänen, Patrik Finne, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2010
Prediction of prostate cancer in unscreened men: external validation of a risk calculatorHeidi A van Vugt, Monique J Roobol, Ries Kranse, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 6, 2008
From registry data collection to international comparisons: examples of haemodialysis duration and frequencyCécile Couchoud, Jeroen Kooman, Patrik Finne, et al.
Clinical Kidney Journal|April 17, 2020
Changes in clinical indicators related to the transition from dialysis to kidney transplantation-data from the ERA-EDTA RegistryPichaya Tantiyavarong, Anneke Kramer, James G Heaf, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 29, 2009
Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry studyDimitrios J Tsakiris, Vianda S Stel, Patrik Finne, et al.
Scientific Reports|October 26, 2022
Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapyPriya Vart, Raphaël Duivenvoorden, Aaltje Adema, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Calcified Tissue International|October 20, 2021
Clinical Prediction of High-Turnover Bone Disease After Kidney TransplantationSatu M Keronen, Leena A L Martola, Patrik Finne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinomaTiina-Liisa Erkinheimo, Heini Lassus, Patrik Finne, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 8, 2025
Effectiveness of COVID-19 vaccination among dialysis and kidney transplant patients compared with matched controls-a nationwide cohort studyHanna Helanne, Elisa Kortela, Jaakko Helve, et al.
European Urology|June 21, 2002
Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examinationPatrik Finne, Anssi Auvinen, Jussi Aro, et al.
International Journal of Cancer|August 10, 2004
Test sensitivity of prostate-specific antigen in the Finnish randomised prostate cancer screening trialAnssi Auvinen, Liisa Määttänen, Patrik Finne, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2010
Prediction of prostate cancer in unscreened men: external validation of a risk calculatorHeidi A van Vugt, Monique J Roobol, Ries Kranse, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 6, 2008
From registry data collection to international comparisons: examples of haemodialysis duration and frequencyCécile Couchoud, Jeroen Kooman, Patrik Finne, et al.
Clinical Kidney Journal|April 17, 2020
Changes in clinical indicators related to the transition from dialysis to kidney transplantation-data from the ERA-EDTA RegistryPichaya Tantiyavarong, Anneke Kramer, James G Heaf, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 29, 2009
Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry studyDimitrios J Tsakiris, Vianda S Stel, Patrik Finne, et al.
Scientific Reports|October 26, 2022
Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapyPriya Vart, Raphaël Duivenvoorden, Aaltje Adema, et al.
Pageof 13